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Helen M. Berman (HMB, pictured) is a Board of Gover-
nors Professor of Chemistry and Chemical Biology at
Rutgers, The State University of New Jersey. Her research
area is structural biology and bioinformatics, with a special
focus on protein–nucleic acid interactions. She is the
founder of the Nucleic Acid Database, a repository of
information about the structures of nucleic acid-containing
molecules; and is the co-founder and Director of the Pro-
tein Data Bank, the international repository of the
structures of biological macromolecules. She is a Fellow of
the American Association for the Advancement of Science
and of the Biophysical Society, from which she received
the Distinguished Service Award in 2000. A past president
of the American Crystallographic Association, she is a
recipient of the Buerger Award (2006). Dr. Berman
received her A. B. in 1964 from Barnard College and a
Ph.D. in 1967 from the University of Pittsburgh.
Interview
WAW: When did you take on the oversight of PDB from
Brookhaven? What were your objectives then? To
what extent have you achieved them?
HMB: The contract with the Research Collaboratory for
Structural Genomics (RCSB) [1] was signed in
October 1998, but there was an overlap of several
months after that. I had been involved with PDB
since 1971 as a co-founder. Brookhaven hosted the
database from 1971 to 1998. During the 1990s
there was a large increase in structures and there
were more users. Then a funding review and an
open competition took place and we won the
contract. I have also been involved for years in
projects for formalizing data formats and gathering
nucleic acid structures, and I had a deep knowledge
of the field. Our objectives were to make PDB a
much richer resource, to produce a searchable
archive, to let users make use of properties in
different ways, to raise awareness, and to introduce
much more rigor in the representation of structures
and encode them in proper databases. We also
wanted to work in a more formal and effective way
with the other international resources at the
European Bioinformatics Institute (EBI) and Osaka
University in Japan to make PDB a more effective
international resource.
WAW: People tell me that the quality of the PDB used to
be poor, but it has improved nowadays. I am told
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that there are no structure factors so the legacy
data cannot be fully evaluated.
HMB: The structures have improved since we made it
our priority within the worldwide PDB (wwPDB)
organization [2] to formalize every aspect of data
validation and data representation. We have
remediated the data to get more uniform format-
ting and nomenclature in the data; all of the
wwPDB annotators work together. The definitions
of data items have been formalized. This is an
ongoing effort but one release of remediated data
has already been done and we are about to do
another release. The underlying data have to be
clean.
Experimental data for older structures are avail-
able for some, but not all, structures. We recently
made it mandatory to submit structure factors and
NMR constraints as part of the deposition process.
The presence of structure factors allows the
wwPDB staff and users to evaluate the quality
of the protein models.
WAW: Do you have sufficient funds?
HMB: The RCSB PDB is funded by grants from the
United States funding agencies, but the funding
mechanisms for PDB worldwide are not what they
should be for this kind of resource. There are
many grants for the PDB Europe (PDBe) effort [3]
at the EBI. PDB Japan (PDBj) at Osaka University
[4] also has multiple grants. All wwPDB centers
have discussed the issues with the funding agen-
cies. We need collaboration mechanisms to make
the funding more coherent, but I am not optimistic
that this will happen. Instability with respect to
funding at any one of the wwPDB centers would
mean trouble for PDB and many users would
suffer.
WAW: Everyone knows about the importance of PDB, but
tell me more about the Protein Structure Initiative
(PSI) [5] and why it matters.
HMB: The initiative started 8 years ago to study struc-
tures at a genomic level and develop technologies
for high throughput structure determination. It was
a post-genomic project, and was very courageous.
The first few years were pilots, funded like
research projects.
WAW: The recent review panel [6] concluded that PSI’s
technology development had been highly success-
ful, did it not?
HMB: Yes. In the second phase [PSI-2] four centers were
identified as production centers [7] and a few
others as specialized technology centers, and these
centers cooperate in a networked way to get
structures out to the public. There is novelty in
what they do. First of all they succeeded in
implementing high throughput pipelines in ways
that had never been seen before, and the structures
are rapidly made available. And the quality of the
structures is very high. All protocols are made
public prior to the appearance of the structure in
the PDB archive, even before the structure is
solved [7]. This is novel data sharing.
WAW: I have just been at a cheminformatics meeting in
Europe and was surprised to find that no-one had
heard of PSI. Someone did say ‘‘Is that the
structural genomics exercise?’’ Has the message
not been spread widely enough?
HMB: The PSI centers were all so busy getting every-
thing done that there was not a big emphasis on
outreach. It takes years before people begin to use
a data resource if there is no outreach. All the
different centers had different web sites with
different unusual names. We consider this a matter
of great importance and are working very hard to
increase the visibility, transparency and profile of
PSI efforts.
WAW: Who conceived the idea of the PSI Structural
Genomics Knowledgebase [8, 9] that you were
appointed to run in summer 2007?
HMB: The key components of the Knowledgebase (KB)
include experimental data tracking, a materials
repository, homology modeling, annotation, tech-
nology development, metrics and outreach. The
Knowledgebase was intended to be a ‘‘one-stop
shop’’ with not just the structures, but with much
more information. All the models from one
structure can be leveraged. There is a portal
where you can type in a sequence and get all the
possible models from a variety of modeling
resources. You get information about the technol-
ogy developed and used by each center. The
construction of the Knowledgebase started last
August. The National Institutes of Health (NIH)
had wanted to build it for a long time, and first
asked me to direct it in June 2007. When we began
work in August we set up a series of portals. The
model portal was set up in Switzerland and the
technology portal at Lawrence Berkeley Labora-
tory. The Core KB portal is at Rutgers. In October
I began to discuss having a Gateway with the
Nature Publishing Group. It will be launched in
September 2008. A prototype of the Knowledge-
base was available in February. This is all brand
new. We have achieved all this in under a year.
WAW: A recent article in Science [10] about the PSI
review panel [6] hardly mentions the Knowledge-
base. Why is that?
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HMB: It takes time. The Science article was written just
when the Knowledgebase was being launched.
WAW: So you really need publicity for the Knowledge-
base. Terry Stouch sent me an enthusiastic
message about PSI.
HMB: Yes. Terry was telling me all the things he had to do
when he wants to know something about a certain
protein and I told him that he could send his sample
to a technology center in Buffalo to determine
crystallization conditions. And there are many
capabilities built into the KB to assist in experi-
mental design. For example, you can retrieve
protocols for protein purification for target
sequences. Having all the protocols out there is
extraordinary. Torsten Schwede of the Swiss Insti-
tute of Bioinformatics has some of the best
modeling resources behind his portal.
WAW: Why are certain structural biologists [10] not
equally enthused?
HMB: It takes time. We have only been doing this for a
matter of months. I am excited about the Gateway.
Nature Publishing Group is providing editorial
help and will write several articles a month about
structural genomics-related projects. The KB site
also hosts a column by David S. Goodsell about
PSI structures similar to his Molecule of the Month
column at the RCSB PDB. The Functional Sleuth
section of the site presents PSI structures that are
lacking functional annotation to encourage dis-
cussion about their possible functions. The KB
will be a resource for all scientists studying living
systems and disease.
WAW: When the PSI-2 assessment report [6] came out
last December, was it too early for the Knowl-
edgebase to be taken into account?
HMB: The PSI-2 assessment was held in September 2007
and the report came out in December. The report
actually says that the Knowledgebase should have
started earlier and I agree: it should have started
3 years ago. If it had, we would have had traction
by now.
WAW: When will the decision be made about funding for
‘‘PSI-3’’?
HMB: There is a meeting October at the NIH to discuss
future structural genomics initiatives. I am looking
forward to being there.
WAW: It was a major goal of PSI to obtain structures of
representatives of as many protein families as
possible [10, 11]. Some biologists want you to
concentrate on proteins of known biological
relevance. Do you think that a compromise can
be or should be reached?
HMB: The family work is relevant to biology. Further,
each center devotes 15% of its effort to a
particular biomedical theme. There is also a big
push in the field of metagenomics. There is a lot of
discussion about all of this and a lot of misinfor-
mation. This is why I am so keen to get the
Knowledgebase out there. The Gateway will get
people to see that we have some gorgeous
structures and novel technologies. The membrane
proteins in particular are really exciting.
WAW: The Gateway launch will not really be early
enough for the October meeting, though. Are
people actually using the Knowledgebase?
HMB: We are measuring activity, and people are using
it. It will take time to get further traction. We also
run TargetDB [8], a database at Rutgers that tracks
the status of each target. That has lots of activity.
People are always looking to see what is going on
there.
WAW: How many people are working on the
Knowledgebase?
HMB: At Rutgers we have one software architect, one
Web programmer, one database programmer and a
systems support person, and we have just hired
one person to do outreach. There is the technology
group at Berkeley, and people in Switzerland to do
the models. I manage those groups by regular
meetings. This is a distributed way of working. I
tend to work in an organic way: I do one thing and
get it working and then I do the next thing and get
that working. Then I put the things together. I also
think we need ongoing community input. Work-
shops, such as the recent one on biological
annotation of novel proteins [12], provided key
input for the annotation module.
WAW: For how long do you have funding?
HMB: We go on year by year. I am assuming that we will
be successful. The next funding cycle starts in July
2009. There are no guarantees in this life but I
hope that we have funds until the end of PSI-2 in
2010. Our steering committee feels strongly that
this should be an enduring exercise.
WAW: What functionality needs to be added?
HMB: We are currently working on standardized anno-
tations for all structures. These can be used to
determine the functions of those structures whose
functions are not known. We want to use estab-
lished annotations that are reliable, for example,
Pfam [13], CATH [14] and SCOP [15], so that you
can see all that you need for prediction of
function.
WAW: How much would ‘‘PSI-3’’ cost, were it approved?
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HMB: I have no idea, but I do believe that the PSI’s high
level of data sharing would be key to its success.
WAW: Is the Knowledgebase critical to the success of
PSI?
HMB: Yes, it is critical, because it will show people what
is going on, but the Knowledgebase goes well
beyond PSI because it will be a paradigm for how
structures are represented.
WAW: This initiative is clearly of great importance to you
personally.
HMB: This is not about me. It is about creating a new
community-based resource. Since I was in my
twenties I have been passionately committed to
open data sharing. There is no point in doing
science otherwise. Science is publicly funded; the
data must not get lost. It is about how science
ought to be done.
WAW: You have achieved much more than most of us
will in our careers but do you have other
ambitions. What other plans do you have for the
future?
HMB: I would like this project to work. I would like to
see the Knowledgebase extended to become a
model for how you represent data. I want to see
much more coherent funding for data infrastruc-
ture. All these data resources exist in constant fear
of disintegration and no stable funding. The
funding agencies (NIH, the National Science
Foundation and the Department of Energy in the
United States, the Biotechnology and Biological
Sciences Research Council in the United Kingdom,
the Wellcome Trust etc.) are national; but science
is global, and funding needs to be stable. Making
this happen is my primary goal before I retire and
hand over the reins. I do not give up easily.
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